I would be interested to know how much pharma lobby cash is behind this decision, especially given MAAPS non-profit status. Because of the legally fraught status of these compounds, dating back to the Nixon war on drugs era, MAAPS has been more than careful every step of the way in bringing these therapies into mainstream medicine. From my experience with FDA, if the right people haven’t already figured out a way to get filthy rich off of a new therapy, ain’t happening until they do.
3 Likes
